‘Must I take all my antibiotics?’ Why infectious disease experts are rethinking this longstanding rule

For decades, doctors have told patients to finish every prescribed course of antibiotics to prevent infections from returning and to stop bacteria from becoming resistant to the drugs. This advice was widely promoted by organizations like the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO). However, recent research suggests this strict rule may not be as necessary as once thought. The idea that stopping antibiotics early leads to antibiotic-resistant bacteria has been challenged by scientists. Instead, the focus is shifting toward using antibiotics only as long as needed to treat the infection effectively, balancing benefits and risks. This change reflects a growing understanding that antibiotic resistance is driven more by overall antibiotic use than by incomplete courses.

A common belief is that stopping antibiotics early allows surviving bacteria to develop resistance, making future infections harder to treat. However, studies show this is not the primary cause of resistance. For example, bacteria causing strep throat have never developed resistance to penicillin, even when infections recur after short treatment courses. Relapses often happen because of reinfection from others or because the antibiotic did not fully reach the infected tissue, leaving some bacteria behind. Resistance is more likely caused by prolonged antibiotic exposure, which kills susceptible bacteria and allows resistant strains to multiply. This process, called selective pressure, increases the proportion of resistant bacteria in the body.

Antibiotics do not only target harmful bacteria causing infections; they also affect the trillions of beneficial bacteria living in the human body, known as the microbiome. These bacteria are found in the gut, mouth, and other areas and play key roles in digestion, immune function, and overall health. Every day a person takes antibiotics, the drug disrupts this delicate balance, killing susceptible bacteria and giving resistant ones a survival advantage. This disruption can last for months or longer. For instance, research published in 2026 showed that prolonged antibiotic use significantly alters the microbiome, increasing the risk of harmful bacteria like Clostridioides difficile (a bacteria causing severe diarrhea) taking over. Reducing unnecessary antibiotic exposure is therefore critical to preserving a healthy microbiome.

Over the past ten years, clinical trials have demonstrated that shorter courses of antibiotics can be just as effective as longer ones for many infections. For example, a 2021 study found that a shorter course of antibiotics worked as well as a longer one for treating bladder infections. Similarly, research on pneumonia in 2016 showed that a five-day course was sufficient for many patients. These findings have led doctors to prescribe much shorter antibiotic courses than they did a decade ago. What used to be a standard 14-day prescription is now often reduced to three, five, or seven days. However, not all infections require shorter treatment. Complicated infections, such as abscesses or those in hard-to-reach tissues, may still need weeks of antibiotics. Additionally, patients with weakened immune systems might require longer treatment to fully clear the infection.

Since 2020, researchers have explored whether patients could stop taking antibiotics once their symptoms improve, rather than completing the full prescribed course. This approach aims to reduce unnecessary antibiotic exposure while ensuring the infection is fully treated. However, this strategy is not straightforward. For some infections, feeling better does not mean the infection is fully gone. Symptoms may fade, but bacteria could still be present, requiring additional treatment to prevent relapse. For example, a 2024 study found that patients with certain infections might feel better after a few days but still need more antibiotics to fully recover. Moreover, symptom improvement is subjective, making it unreliable as a guide for stopping treatment. A better solution is for doctors to avoid prescribing antibiotics unnecessarily in the first place.

Despite growing awareness, antibiotic overprescription remains a significant global problem. A 2025 review of 412 studies estimated that about one-third of all antibiotic prescriptions worldwide are inappropriate. This is particularly true for viral infections like colds, flu, and most sinus infections, which do not respond to antibiotics. When patients take antibiotics for these conditions and start feeling better after a few days, it is usually because their immune system cleared the infection, not because the antibiotic helped. Overprescription not only contributes to antibiotic resistance but also disrupts the microbiome unnecessarily. Addressing this issue requires doctors to carefully evaluate whether antibiotics are truly needed and to prescribe the shortest effective duration when they are.